Elusys Therapeutics, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche/Genentech Bring In Cell Therapy C

In 2017, while working in a drug pricing and commercialization consultancy, I prepared a slide analyzing the 2016 sales of the 35 novel drugs that were approved in 2011. I have just repeated the exerc

In 2020, 42 products containing a total of 41 new active substances received an EU marketing authorization, a sharp increase on the 28 NAS-containing products that were cleared in 2019, and just short

The seven marketing authorization applications (MAAs) that are up for an opinion this week on whether they should be marketed in the EU include two vaccines from Sanofi – one for the prevention of i